Journal Papers 12 Related Insights 0
A Phase 1 study of the safety, tolerability, and pharmacokinetics of ALG-000184 (pevifoscorvir sodium), a novel Class E capsid assembly modulator, in healthy participants Gane, Ed; Schwabe, Christian; Wu, Min; Lin, Tse-, I; Blatt, Lawrence; Fry, John; Chanda, Sushmita; Le, Kha Share Save
Best practices for screening, testing, diagnosing, and treating patients with hepatitis D (delta) virus based on global expert review and recent guidelines Cornberg, Markus; Zoulim, Fabien; Gish, Robert; Jacobson, Ira M.; Kushner, Tatyana; Lampertico, Pietro; Rizzetto, Mario; Yurdaydin, Cihan; Manns, Michael Share Save
Pharmacokinetic and mass balance characterization of [14C] RAY1216, a SARS-CoV-2 Mpro inhibitor, in healthy Chinese male subjects Hu, Wang; Ding, Jiaxiang; Xie, Yunqiu; Zhang, Tonghao; Peng, Yu; Wang, Ying; Wang, Xiaoni; Xu, Peng; Li, Xiaoli; Wang, Xuefeng; Wang, Heyue; Cheng, Ning; Zhou, Jinmei; Sun, Luning; Zhou, Huan; Qi, Qi Share Save
Baseline CD4+ T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients Ciccarelli, Nicoletta; Grima, Pierfrancesco; Fabbiani, Massimiliano; Baldonero, Eleonora; Borghetti, Alberto; Milanini, Benedetta; Limiti, Silio; Colafigli, Manuela; Tamburrini, Enrica; Cauda, Roberto; De Luca, Andrea; Di Giambenedetto, Simona Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
